News - TransCelerate BioPharma, Abbott Laboratories


Popular Filters

1 to 25 of 78 results

New Zealand to fully subsidize Abbott Lab’s Ferrograd

New Zealand to fully subsidize Abbott Lab’s Ferrograd


New Zealand’s Pharmaceutical Management Agency PHARMAC has approved an agreement with the local subsidiary…

Abbott LaboratoriesAsia-PacificFerrogradFinancialHematologyPharmaceutical

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing


In further legal action against drugmakers allegedly over pricing AIDS drugs in the USA, the AIDS Healthcare…

Abbott LaboratoriesAbbVieAnti-viralsKaletra TabletsLegalNorth AmericaNorvirPharmaceuticalPricing

Abbott Labs beats forecasts, despite China woes

Abbott Labs beats forecasts, despite China woes


Abbott Laboratories, which last year spun off its research-based prescription medicines into AbbVie,…

Abbott LaboratoriesFinancialPharmaceutical

Agreements for influenza vaccine approved in New Zealand


New Zealand’s PHARMAC has reached agreements with subsidiaries of GlaxoSmithKline and Abbott Laboratories…

Abbott LaboratoriesFluarixGlaxoSmithKlineHealthcareInfluvacNew ZealandPharmaceuticalPricingVaccines

New Zealand proposals for influenza vaccines


New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to list two…

Abbott LaboratoriesAsia-PacificFluarixGlaxoSmithKlineInfluvacPharmaceuticalPricingRegulationVaccines

US FDA warns pregnant women to not use valproate migraine prevention medicines


The US Food and Drug Administration is alerting health care providers and patients that medications including…

Abbott LaboratoriesGenericsNeurologicalNorth AmericaNoven PharmaceuticalsPharmaceuticalRegulationSanofivalproate Sodium Injection

Leading Russian vaccines producer Petrovax acquired by Pharmstandard


Russian drugmaker Pharmstandard is to acquire Petrovax Pharm, one of the country's largest producers…

Abbott LaboratoriesMergers & AcquisitionsPetrovax FarmPharmaceuticalPharmstandardVaccines

Abbott Labs told it cannot acquire Russia's Petrovax Farm


The Russian government has imposed a ban on the sale of Petrovax Farm, one of Russia's leading vaccines…

Abbott LaboratoriesBiotechnologyMergers & AcquisitionsPetrovax FarmVaccines

Positive Ph III results for AbbVie's Humira in pediatric Crohn's disease; five leukemia studies suspended


AbbVie (NYSE: ABBV), the new spin-out from Abbott Laboratories, has announced the first long-term, patient-reported…

Abbott LaboratoriesAbbVieAnti-Arthritics/RheumaticsGastro-intestinalsHumiraOncologyPharmaceuticalResearch

AbbVie inaugural full-year outlook for 2013 in line with expectations


Newly spun-out from Abbott Labs, research-based pharma company AbbVie (NYSE: ABB) yesterday confirmed…

Abbott LaboratoriesAbbVieFinancialPharmaceuticalResearch

Abbott Labs 4th-qtr net income plunges


US health care major Abbott Laboratories (NYSE: ABT) posted sales of $10.84 billion for the fourth quarter…

Abbott LaboratoriesFinancialPharmaceutical

Abbott board prepares way for AbbVie split off


US health care giant Abbott Laboratories (NYSE: ABT) says that its board of directors has approved the…

Abbott LaboratoriesAbbVieFinancialPharmaceutical

Biosimilars threaten to burst Humira's blockbuster bubble


US health care major Abbott Laboratories' (NYSE: ABT) Humira (adalimumab) has a strong reputation as…

Abbott LaboratoriesAnti-Arthritics/RheumaticsBiotechnologyGenericsHumiraMarkets & Marketing

EU Commission approves Bayer's Eylea for wet AMD and Abbott's Humira for pediatric Crohn's


There was good news yesterday for Germany's Bayer (BAYN: DE) and US health care major Abbott Laboratories…

Abbott LaboratoriesBayerEuropeEyleaGastro-intestinalsHumiraOphthalmicsPharmaceuticalRegeneronRegulation

Abbott launches Sucampo's Amitiza in Japan


US drugmaker Sucampo Pharmaceuticals (Nasdaq: SCMP), and marketing partner health care major Abbott Laboratories…

Abbott LaboratoriesAmitizaAsia-PacificGastro-intestinalsMarkets & MarketingPharmaceuticalSucampo

Janssen starts new trial investigator databank, joined by Merck & Co and Lilly


Janssen Research & Development, a unit of health care giant Johnson & Johnson (NYSE: JNJ) yesterday announced…

BiotechnologyPharmaceuticalResearchTransCelerate BioPharma

Abbott presents new Humira data at ACR


US pharma major Abbott Laboratories (NYSE: ABT) today announced results from a post-hoc analysis of its…

Abbott LaboratoriesAnti-Arthritics/RheumaticsHumiraPharmaceuticalResearch

Abbott Labs' AbbVie bond deal hit $37 billion yesterday, sources report


US health care major Abbott Laboratories (NYSE: ABT) and its subsidiary AbbVie came to market early Monday…

Abbott LaboratoriesAbbVieFinancialPharmaceutical

AET BioTech and BioXpress to co-develop biosimilar Humira


Plans to develop another biosimilar version of Abbott Laboratories blockbuster rheumatoid arthritis drug…

Abbott LaboratoriesadalimumabAET BioTechAnti-Arthritics/RheumaticsBiotechnologyBioXpress TherapeuticsGenericsHumiraProductionResearch

Seattle Genetics and Abbott expand ADC collaboration


Seattle Genetics and Abbott expand ADC collaboration

Abbott LaboratoriesBiotechnologyLicensingOncologyPharmaceuticalSeattle Genetics

1 to 25 of 78 results

Back to top